ILUMETRI 100 mg SOLUTION FOR INJECTION IN PRE-FILLED SYRINGE

2. What you need to know before you use Ilumetri

Do not use Ilumetri:

• If you are allergic to tildrakizumab or any of the other ingredients of this medicine (listed in section 6).
• If you have an infection that your doctor thinks is important, for example, active tuberculosis, which is an infectious disease that mainly affects the lungs.

Warnings and precautions

Consult your doctor, pharmacist, or nurse before starting Ilumetri:

• If you have allergic reactions with symptoms such as chest tightness, wheezing, swelling of the face, lips, or throat, do not inject more Ilumetri and contact your doctor immediately.
• If you currently have an infection or if you get long-term or repeated infections.
• If you have been recently vaccinated or are planning to be vaccinated.

If you are not sure if you are in any of the above circumstances, consult your doctor, pharmacist, or nurse before using Ilumetri.

Each time you receive a new pack of Ilumetri, it is important that you note the date and batch number (which appears on the packaging after "Batch") and keep this information in a safe place.

Monitoring of infections and allergic reactions

Ilumetri may cause serious side effects, such as infections and allergic reactions. You should be alert to the signs of these conditions while using Ilumetri.

Stop using Ilumetri and inform your doctor or seek medical attention immediately if you notice signs that may indicate a serious infection or an allergic reaction (see section 4. Possible side effects).

Children and adolescents

Ilumetri is not recommended for use in children and adolescents under 18 years of age, as it has not been evaluated in this patient group.

Other medicines and Ilumetri

Tell your doctor or pharmacist if you are using, have recently used, or might use any other medicines. This includes vaccines and immunosuppressive medicines (medicines that affect the immune system).

Certain types of vaccines (live vaccines) should not be given while using Ilumetri. There are no data available on the use of Ilumetri and live vaccines at the same time.

Pregnancy, breastfeeding, and fertility

It is recommended to avoid using Ilumetri during pregnancy. The effects of this medicine on pregnant women are not known.

If you are a woman of childbearing age, it is recommended that you do not become pregnant and should use an effective contraceptive method while receiving treatment with Ilumetri and for at least 17 weeks after stopping treatment.

If you are pregnant or breastfeeding, think you may be pregnant, or plan to become pregnant, consult your doctor or pharmacist before using this medicine.

Driving and using machines

Ilumetri has no or negligible influence on the ability to drive and use machines.

Ilumetri contains polysorbates

This medicine contains 0.5 mg of polysorbate 80 (E 433) in each pre-filled syringe, equivalent to 0.5 mg/ml. Polysorbates may cause allergic reactions. Inform your doctor if you have any known allergy.

3. How to use Ilumetri

Ilumetri should be used under the direction and supervision of a doctor with experience in the diagnosis and treatment of psoriasis.

Follow exactly the administration instructions of this medicine as indicated by your doctor. If in doubt, consult your doctor or pharmacist again. This medicine is for single use.

The recommended dose of Ilumetri is 100 mg by subcutaneous injection at weeks 0 and 4 and every 12 weeks thereafter.

If you are a patient with a high disease burden or with a body weight over 90 kg, your doctor may recommend a dose of 200 mg.

Your doctor will decide the duration of treatment with Ilumetri.

After you have learned the injection technique correctly, you can inject Ilumetri yourself if your doctor considers it appropriate.

To consult the instructions on how to inject Ilumetri, read the "Instructions for use" at the end of this leaflet.

Consult your doctor when you will have injections and follow-up visits.

Use in children and adolescents

The safety and efficacy of Ilumetri in children and adolescents under 18 years of age have not been established, so the use of Ilumetri in children and adolescents is not recommended.

If you use more Ilumetri than you should

If more Ilumetri has been administered than it should or the dose has been administered earlier than indicated by the doctor's prescription, inform your doctor.

If you forget to use Ilumetri

If you have forgotten or missed an injection of Ilumetri, administer the dose as soon as possible. Then, resume administration at the usual interval.

If you stop treatment with Ilumetri

The decision to stop treatment with Ilumetri should be made together with your doctor. It is possible that your symptoms may reappear when stopping treatment.

If you have any other questions about the use of this medicine, ask your doctor, pharmacist, or nurse.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Serious side effects

If you notice any of the following symptoms, contact your doctor immediately:

• Swelling of the face, lips, or throat
• Difficulty breathing

These may be signs of an allergic reaction.

Other side effects

Most of the following side effects are mild. If any of the following side effects gets serious, inform your doctor or pharmacist.

Very common(may affect more than 1 in 10 people)

• Upper respiratory tract infections

Common(may affect up to 1 in 10 people)

• Gastroenteritis
• Nausea
• Diarrhea
• Pain at the injection site
• Back pain
• Headache

Reporting of side effects

If you experience any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly through the national reporting system listed in Appendix V. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Ilumetri

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the carton and on the label of the pre-filled syringe after EXP. The expiry date refers to the last day of the month shown.

Store the medicine in the original package to protect it from light. Do not shake.

Store in a refrigerator (between 2°C and 8°C). Do not freeze.

After removing the pre-filled syringe from the refrigerator, wait approximately 30 minutes for the Ilumetri solution in the syringe to reach room temperature (maximum 25°C). Do not heat it in any other way.

Do not use if the liquid contains visible particles, is cloudy, or is clearly brown.

Once removed from the refrigerator, do not store tildrakizumab at more than 25°C or refrigerate it again.

In the space provided on the outer carton, note the date you removed the medicine from the refrigerator and the disposal date that corresponds. Use the syringe before 30 days have passed since it was removed from the refrigerator or before the expiry date, whichever comes first.

Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. This will help protect the environment.

6. Container Contents and Additional Information

Composition of Ilumetri

• The active substance is tildrakizumab. Each pre-filled syringe contains 100 mg of tildrakizumab.
• The other components are L-histidine, L-histidine hydrochloride monohydrate, polysorbate 80 (E 433), sucrose, and water for injectable preparations.

Appearance ofIlumetriand Container Contents

Ilumetri 100 mg solution for injection (injection) in pre-filled syringe is a clear or slightly opalescent solution, colorless to slightly yellowish.

Ilumetri 100 mg solution for injection (injection) in pre-filled syringe is available in single units with 1 pre-filled syringe and in packs with 2 pre-filled syringes.

Only some pack sizes may be marketed.

Marketing Authorisation Holder

Almirall, S.A.

Ronda General Mitre, 151

08022 Barcelona, Spain

Manufacturer

SUN Pharmaceuticals Industries (Europe) B.V.

Polarisavenue 87

2132JH Hoofddorp, Netherlands

Almirall, S.A.

Ctra. de Martorell 41-61

08740 Sant Andreu de la Barca, Barcelona, Spain

You can request more information about this medicinal product by contacting the local representative of the marketing authorisation holder:

Date of Last Revision of this Leaflet: 06/2024

Other Sources of Information

Detailed information on this medicinal product is available on the European Medicines Agency website https://www.ema.europa.eu/.

INSTRUCTIONS FOR USE

Before using the pre-filled syringes:

Important Points to Know

• Before using the Ilumetri pre-filled syringes, read and follow all the step-by-step instructions carefully. Keep the instructions for use and consult them when needed.
• The pre-filled syringes must not be shaken.
• Read the Ilumetri package leaflet for more information about the medicinal product.

DESCRIPTION OF THE PRODUCT

The Ilumetri pre-filled syringe looks like this:

PREPARATION

1. Take the container out of the refrigerator (if stored in the refrigerator)
   • Make sure the dose on the syringe corresponds to the dose prescribed by your doctor.
   • A dose of 100 mg requires one syringe and a dose of 200 mg requires two syringes.
   • Take the box out of the refrigerator and place it unopened on a clean and flat work surface.

1. Wait for 30 minutes (if stored in the refrigerator)
   • Leave the pre-filled syringe in the outer carton (with the lid closed) at room temperature for 30 minutes.

1. Inspect the medicinal product
   • Take the pre-filled syringe out of the carton when you are ready for injection.
   • • Check the expiry date on the carton and on the pre-filled syringe and discard it if the date has passed.
     • DO NOT remove the needle cap until you are ready to administer the injection.
   • Before administering Ilumetri, visually inspect it for particles and color change.
   • • Ilumetri is a clear or slightly opalescent solution, colorless to slightly yellowish.
     • DO NOT use it if the liquid contains visible particles or if the syringe is damaged. It is possible that there may be air bubbles; there is no need to remove them.
     • DO NOT use the product if it has been dropped onto a hard surface or is damaged.

1. Gather all the materials you need
   • On a clean and well-lit work surface, place the following:

• alcohol swabs
• cotton ball or gauze
• plaster
• container for disposing of sharp objects

1. Wash your hands
   • Wash your hands well with water and soap.

1. Choose the injection site
   • Choose a place to administer the injection where the skin is healthy and easily accessible, such as the abdomen, thighs, or upper arm.
   • • DO NOT administer the injection in the 5 cm around the navel or in areas of skin with sensitivity, bruising, abnormal redness, hardening, or psoriasis lesions.
     • DO NOT inject into scars, stretch marks, or blood vessels.
     • The upper arm is only suitable if the injection is administered by another person.
     • Alternate injection sites for each administration.
     • If your dose is 200 mg (2 pre-filled syringes of 100 mg), choose a different site for the second injection.

1. Clean the injection site
   • Clean the injection site with an alcohol swab and let the skin dry.

• Do not touch this area again before administering the injection.

INJECTION

If your dose is 200 mg, you will need to use 2 pre-filled syringes each time you administer the medicinal product.

1. Remove the needle cap
   • While holding the body of the pre-filled syringe, remove the needle cap as shown and discard it. You may see 1 or 2 drops of liquid, which is normal.

• DO NOT touch the blue plunger yet.
• DO NOT use the product if the pre-filled syringe or needle is bent.

1. Pinch the skin and insert the needle
   • Gently pinch the skin at the chosen injection site.
   • Insert the entire needle into the pinched skin between your fingers, at an angle of 45 to 90 degrees.

• DO NOT place your finger on the plunger while inserting the needle.

• Hold the pre-filled syringe firmly.

1. Administer the injection
   • Once the needle is inserted, gently release the skin.
   • Push the blue plunger down until it reaches the stop. This activates a safety mechanism that ensures the complete retraction of the needle after the injection is administered.

• If the blue plunger reaches the stop, it cannot be moved further and there are no spills, a full dose has been administered.

1. Remove the used syringe
   • Completely remove the needle from the skin before releasing the blue plunger.

• After releasing the blue plunger, the safety lock will pull the needle into the needle shield.

• Discard the used syringe in a container for disposing of sharp objects immediately after use and before administering a second syringe, if necessary.
• If there is any residual liquid or a little blood, clean the injection site with a cotton ball or gauze while applying pressure. If necessary, you can use a plaster to cover the injection site.
• Repeat the procedure with the second syringe in a different skin area if you are administering a dose of 200 mg.